<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>米内网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-04T20:33:14+08:00</updated>
  <subtitle>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>17个独家妇科中成药“霸屏”TOP20！千金、步长、康缘……十大过亿品牌曝光，4个逆势增长</title>
    <updated>2020-12-04T16:46:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/zms6JGQvoV_YMzaviV03WQ</id>
    <link href="https://mp.weixin.qq.com/s/zms6JGQvoV_YMzaviV03WQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【10周年献礼】石药集团：米内数据源强大，可视化图表呈现，公众号资讯及时性强</title>
    <updated>2020-12-04T16:46:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/AKIHjbSBVXMuJA2npl8DOw</id>
    <link href="https://mp.weixin.qq.com/s/AKIHjbSBVXMuJA2npl8DOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【市场】抗乙肝病毒药市场“激战”！倍特首仿获批后，青峰、齐鲁紧跟而至</title>
    <updated>2020-12-04T16:46:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/5xGLa0sWfkfvwL1KPORF_w</id>
    <link href="https://mp.weixin.qq.com/s/5xGLa0sWfkfvwL1KPORF_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】扬子江发威！拿下两个超10亿注射剂首家过评</title>
    <updated>2020-12-04T16:46:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/_nGbKGOqPJoNQdPxtlRxFg</id>
    <link href="https://mp.weixin.qq.com/s/_nGbKGOqPJoNQdPxtlRxFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>千亿龙头这样赚钱：恒瑞攻创新，23个1类新药齐开花；中生抢首仿拼集采，绝招是……</title>
    <updated>2020-12-03T16:29:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/Y9yNMLG-TIy9fKoDt1SkxQ</id>
    <link href="https://mp.weixin.qq.com/s/Y9yNMLG-TIy9fKoDt1SkxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】海思科1类新药即将获批！百亿麻醉剂市场炸裂</title>
    <updated>2020-12-03T16:29:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/PWHdhN6GcV-uFsG7efKudw</id>
    <link href="https://mp.weixin.qq.com/s/PWHdhN6GcV-uFsG7efKudw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】齐鲁新入局！苑东、豪森、倍特猛攻$15亿抗血栓大品种</title>
    <updated>2020-12-03T16:29:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/I30CuPPIj4V3piP1Q_5rjg</id>
    <link href="https://mp.weixin.qq.com/s/I30CuPPIj4V3piP1Q_5rjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>四川药企发威！科伦14个首仿、13款新药亮眼，倍特发力吸入剂，汇宇猛攻注射剂</title>
    <updated>2020-12-02T15:54:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/sizl2sIecIW4AVqT4V_9lw</id>
    <link href="https://mp.weixin.qq.com/s/sizl2sIecIW4AVqT4V_9lw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【10周年献礼】华润三九：及时更新的品类划分是构建产品信息情报网的重要抓手</title>
    <updated>2020-12-02T15:54:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/aKhxlB_EGCflx07bz5ubRA</id>
    <link href="https://mp.weixin.qq.com/s/aKhxlB_EGCflx07bz5ubRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】东阳光药厉害了，3大重磅新品将获批</title>
    <updated>2020-12-02T15:54:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/Upn2B7ExbFwmA-_imdubLQ</id>
    <link href="https://mp.weixin.qq.com/s/Upn2B7ExbFwmA-_imdubLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【FDA】4个新药3个为全球“首款”，今年以来46款创新药已获批</title>
    <updated>2020-12-02T15:54:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/60hwIL0BPyuR2facOim8Tw</id>
    <link href="https://mp.weixin.qq.com/s/60hwIL0BPyuR2facOim8Tw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百亿骨科中成药零售TOP20出炉！奇正、羚锐、白云山……上榜，20亿大品种跌落“神坛”</title>
    <updated>2020-12-01T16:57:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/_L8lbFRQMn3FI5F3frh9qA</id>
    <link href="https://mp.weixin.qq.com/s/_L8lbFRQMn3FI5F3frh9qA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【10周年献礼】振东制药：得信息者得天下，让数据为发展说话</title>
    <updated>2020-12-01T16:57:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/bSEpK2xXnLKZ8MAT3zavCQ</id>
    <link href="https://mp.weixin.qq.com/s/bSEpK2xXnLKZ8MAT3zavCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】东阳光药1类新药获批临床！剑指千亿市场</title>
    <updated>2020-12-01T16:57:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/QP4n-E72k9f-ktUuLqBucA</id>
    <link href="https://mp.weixin.qq.com/s/QP4n-E72k9f-ktUuLqBucA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【市场】47亿注射剂！齐鲁、豪森将打破汇宇独家过评局面</title>
    <updated>2020-12-01T16:57:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/DJH_4Rti9T7WUAqIbLG_Ww</id>
    <link href="https://mp.weixin.qq.com/s/DJH_4Rti9T7WUAqIbLG_Ww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>心血管超10亿品牌曝光：石药涨近三成，施慧达零售耀眼！三大产品要集采？</title>
    <updated>2020-11-30T16:12:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/9I1TcNOaBEZ-P5B0-ncnfA</id>
    <link href="https://mp.weixin.qq.com/s/9I1TcNOaBEZ-P5B0-ncnfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【10周年献礼】立方制药：销售高增长与米内的精准市场信息密不可分</title>
    <updated>2020-11-30T16:12:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/ZVhzVkgF8sqCvZMpPTXIZQ</id>
    <link href="https://mp.weixin.qq.com/s/ZVhzVkgF8sqCvZMpPTXIZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】齐鲁又要抢首仿！三大在审滴眼液冲击百亿市场</title>
    <updated>2020-11-30T16:12:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/zt_mQ4eY29phdivrPsPG3w</id>
    <link href="https://mp.weixin.qq.com/s/zt_mQ4eY29phdivrPsPG3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【焦点】60亿注射剂奥赛康首家过评，普利、一品抢30亿市场</title>
    <updated>2020-11-30T16:12:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/VjVl5IjqCv8RMAsLl7wtFg</id>
    <link href="https://mp.weixin.qq.com/s/VjVl5IjqCv8RMAsLl7wtFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞、先声、石四药……67个新药获批临床！豪森拿下首个口溶膜制剂，默沙东新药来了</title>
    <updated>2020-11-29T07:57:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/wuv6pljrnR1kfeH_ycyvWg</id>
    <link href="https://mp.weixin.qq.com/s/wuv6pljrnR1kfeH_ycyvWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>